Tashiro C, Yuasa S, Demizu K
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd., Japan.
Yakugaku Zasshi. 1992 Feb;112(2):108-14. doi: 10.1248/yakushi1947.112.2_108.
Four alcoholic metabolites of (+-)-3-chloro-5-[3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo[1,2-a] pyridine-3-spiro-4'-peperidino)propyl]-10,11-dihydro-5'-dibenz[b,f ] azepine(mosapramine), a new antipsychotic drug, were synthesized in order to determine their chemical structures. A mixture of 10-ethoxy-3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine and 11-ethoxy isomer was used as a starting material. Isomeric intermediates, i.e. 10-oxo-3-chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine and 11-oxo isomer, were separated by chromatography with silica gel. The metabolites were obtained by NaBH4 reduction of the corresponding 10-oxo or 11-oxo compounds followed by introduction of spiro-piperidine moieties into propyl side chain.
为确定新型抗精神病药物(±)-3-氯-5-[3-(2-氧代-1,2,3,5,6,7,8,8a-八氢咪唑并[1,2-a]吡啶-3-螺-4'-哌啶基)丙基]-10,11-二氢-5H-二苯并[b,f]氮杂卓(莫沙帕明)的四种酒精代谢物的化学结构,对其进行了合成。以10-乙氧基-3-氯-10,11-二氢-5H-二苯并[b,f]氮杂卓和11-乙氧基异构体的混合物作为起始原料。通过硅胶柱色谱法分离出异构中间体,即10-氧代-3-氯-5-(3-氯丙基)-10,11-二氢-5H-二苯并[b,f]氮杂卓和11-氧代异构体。通过用硼氢化钠还原相应的10-氧代或11-氧代化合物,然后在丙基侧链引入螺哌啶部分来获得代谢物。